Latest Period
Q2 2026
Security Snapshot
INTENSITY THERAPEUTICS, INC. - COM NEW (INTS) Institutional Ownership
CUSIP: 45828J202
13F Institutional Holders and Ownership History from Q1 2026 to Q2 2026
Institutions Reporting
17
Shares (Excl. Options)
1,168,711
Price
$4.10
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM NEW
- Symbol
- INTS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,168,711
- Total 13F value
- $4,791,514
- Portfolio coverage rank
- 0%
- Share change
- +988,431
- Value change
- +$4,052,030
- Number of holders
- 17
- SEC-reported price per share
- $4.16
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- INTS - INTENSITY THERAPEUTICS, INC. - COM NEW is tracked under CUSIP 45828J202.
- 17 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 14 to 17 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,060,045 to $4,791,514.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 17 institutions filings for Q2 2026.
Security key
45828J202
Latest holder period
Q2 2026
13F holders
17
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
INTS full holder history
INTENSITY THERAPEUTICS, INC. SEC filings
INTENSITY THERAPEUTICS, INC. company facts
INTENSITY THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45828J202:
As of 30 Jun 2026, 17 institutional investors reported holding 1,168,711 shares of INTENSITY THERAPEUTICS, INC. - COM NEW (INTS).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q2 2026
Rows shown
1-2 of 2